|
|
|
Abstract Objective: To investigate the clinical effect of MCu II functional intrauterine device (IUD) insertion during cesarean section. Methods: Women with term delivery who seeking for cesarean section were divided into three groups. Women in group A (n=120) were inserted IUD during cesarean section, those in group B (n=120) were not inserted IUD, and those in group C (n=120) were inserted IUD 6 month after cesarean section. The amount of intraoperative and postoperative bleeding, puerperal morbidity, duration of bloody lochia and the degree of puerperal involution of uterus 42 days after delivery of group A and B were evaluated. The menstrual cycle, menstrual period, amount of menstruation 1 years after delivery, the incidence of postoperative side effects, the heterotopic and expulsion rates and the pregnancy rate with IUD in situ of group A and C were observed. Results: There were no significant differences in the amount of intraoperative and postoperative bleeding, puerperal morbidity, duration of bloody lochia and the degree of puerperal involution of uterus 42 days after delivery between group A and C (P>0.05). And there were no significant differences in the menstrual cycle, menstrual period, amount of menstruation 1 years after delivery, the incidence of postoperative side effects, the heterotopic and expulsion rates and the pregnancy rate with IUD in situ between group A and C (P>0.05). Conclusion: MCu Ⅱ functional intrauterine device insertion during cesarean section is safe and effective and would be worthy of popularizing for clinical application.
|
|
|
|
|
|
|
|
